Rifaximin Predicts the Complications of Decompensated Cirrhosis
Clinical trial NCT02074280 · UNKNOWN
Trial details
- NCT number
- NCT02074280
- Sponsor
- Shanghai Changzheng Hospital
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2013-10-01
- Primary completion
- 2014-06-01
- Enrollment
- 250
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.